The most common version, CJC-1295 with DAC (Drug Affinity Complex) , binds to albumin in the bloodstream and remains active for several days
However, it has not received approval as a medical product from the US Food and Drug Administration (FDA), and studies on its use in humans are lacking
Currently, there are no known severe medication interactions
Additionally, it helps protect the heart and central nervous system from oxidative damage
There are no Therapeutic Use Exemptions (TUEs) for BPC-157, and its presence in an athletes system can lead to disqualification
As a result, injectable glutathione offers superior absorption and faster, more noticeable results